UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of Report (Date of earliest event reported): May 19, 2003
HEMACARE CORPORATION
(Exact Name of Registrant as Specified in its Charter)
CALIFORNIA
(State or other jurisdiction of incorporation)
000-15223 95-3280412
(Commission File No.) (IRS Employer Identification No.)
21101 Oxnard Street
Woodland Hills, CA 91367
(Address of principal executive offices and Zip Code)
Registrant's telephone number, including area code: (818) 226-1968
2
ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE
The text of a press release dated May 19, 2003, issued by
HemaCare Corporation ("HemaCare") announcing the appointment of
Wm. Andrew Heaton, MD and Terry Van Der Tuuk to its Board of
Directors is attached as Exhibit 99.1 hereto and is incorporated by
reference herein.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits
Exhibit
Number Description
------- -----------------------------------------------------
99.1 Press Release issued by HemaCare, dated May 19, 2003
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
Date: May 19, 2003 HEMACARE CORPORATION
/s/ Judi Irving
--------------------------
Judi Irving,
Chief Executive Officer
2
3
EXHIBIT INDEX
Exhibit
Number Description
------- ----------------------------------------------------
99.1 Press Release issued by HemaCare, dated May 19, 2003
3